サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1676147

個別化医療の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）

Global Personalized Medicine Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 137 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
個別化医療の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 137 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の個別化医療市場規模は、2024年の4,415億1,000万米ドルから2033年には1兆5,678億3,000万米ドルに成長し、2026年から2033年の予測期間中に15.12％の堅調な年間平均成長率（CAGR）を示すと予測されます。

ゲノムとバイオテクノロジーの進歩により、オーダーメイドのヘルスケアソリューションが可能になるため、個別化医療市場は大きく成長する見込みです。個別化医療は、遺伝的体質、ライフスタイル、環境要因など、個人の特性に基づいて治療をカスタマイズするものです。慢性疾患の増加や標的治療に対する需要の高まりが個別化医療への投資を促進し、市場の拡大をさらに後押ししています。さらに、患者の転帰の改善とヘルスケアコストの削減が重視されていることも、治療における個別化アプローチの採用に寄与しています。

技術の進歩は、個別化医療市場の将来を形作る上で重要な役割を果たしています。ゲノム配列決定、バイオインフォマティクス、データ分析における革新は、特定のバイオマーカーを特定し、標的療法を開発する能力を高めています。さらに、人工知能と機械学習の統合により、ヘルスケアプロバイダーは膨大な量のデータを分析し、十分な情報に基づいた治療選択肢に関する意思決定を行うことができるようになっています。業界が進化を続ける中、個別化医療市場では、さまざまなヘルスケア環境においてテクノロジー主導型ソリューションの採用が進むとみられます。

さらに、患者の関与と教育を重視する傾向が強まっていることも、個別化医療市場の成長軌道に影響を与えています。患者が自分の健康状態や治療の選択肢についてより多くの情報を得るようになるにつれて、患者固有のニーズに対応する個別化ソリューションに対する需要が高まっています。この動向は、医療提供者、製薬会社、テクノロジー企業間の協力関係を促進し、患者が医療上の意思決定において積極的な役割を果たせるような教育リソースや支援システムの開発を促しています。市場が進化し続ける中、テクノロジー、患者エンゲージメント、個別化ケアの統合が成功の鍵となるでしょう。

当社のレポートは、様々な業界や市場に関する包括的かつ実用的な洞察をお客様に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：

市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主な促進要因・抑制要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 個別化医療産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 個別化医療の世界市場分析：製品タイプ別

  • 概要：製品タイプ別
  • 実績および予測データ分析：製品タイプ別
  • 診断薬
  • 治療薬
  • 個別化医療
  • その他

第6章 個別化医療の世界市場分析：用途別

  • 概要：用途別
  • 実績および予測データ分析：用途別
  • 腫瘍学
  • 循環器
  • 神経学
  • 感染症
  • その他

第7章 個別化医療の世界市場分析：技術別

  • 概要：技術別
  • 実績および予測データ分析：技術別
  • ゲノミクス
  • ファーマコゲノミクス
  • コンパニオン診断
  • その他

第8章 個別化医療の世界市場分析：エンドユーザー別

  • 概要：エンドユーザー別
  • 実績および予測データ分析：エンドユーザー別
  • 病院
  • 診断センター
  • 研究機関
  • その他

第9章 個別化医療の世界市場分析：地域別

  • 地域別の展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第10章 個別化医療企業の競合情勢

  • 個別化医療市場の競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Roche
  • Thermo Fisher Scientific
  • Illumina
  • GE Healthcare
  • Abbott Laboratories
  • Danaher Corporation
  • Qiagen
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Hologic
  • Exact Sciences
  • PerkinElmer
  • Myriad Genetics
  • Foundation Medicine
  • Invitae Corporation
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (USD MN)
  • Diagnostics Market Sales By Geography (USD MN)
  • Therapeutics Market Sales By Geography (USD MN)
  • Personalized Medical Care Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Cardiology Market Sales By Geography (USD MN)
  • Neurology Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Technology (USD MN)
  • Genomics Market Sales By Geography (USD MN)
  • Pharmacogenomics Market Sales By Geography (USD MN)
  • Companion Diagnostics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Research Laboratories Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Personalized Medicine Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Personalized Medicine Report
  • Market Research Process
  • Market Research Methodology
  • Global Personalized Medicine Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By End-User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type (USD MN)
  • Diagnostics Market Sales By Geography (USD MN)
  • Therapeutics Market Sales By Geography (USD MN)
  • Personalized Medical Care Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Cardiology Market Sales By Geography (USD MN)
  • Neurology Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Technology (USD MN)
  • Genomics Market Sales By Geography (USD MN)
  • Pharmacogenomics Market Sales By Geography (USD MN)
  • Companion Diagnostics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Research Laboratories Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11219103

Global Personalized Medicine Market size is anticipated to grow from USD 441.51 Billion in 2024 to USD 1567.83 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 15.12% during the forecast period of 2026 to 2033.

The Personalized Medicine Market is poised for significant growth as advancements in genomics and biotechnology enable tailored healthcare solutions. Personalized medicine involves customizing medical treatment based on individual characteristics, such as genetic makeup, lifestyle, and environmental factors. The increasing prevalence of chronic diseases and the growing demand for targeted therapies are driving investments in personalized medicine, further propelling market expansion. Additionally, the emphasis on improving patient outcomes and reducing healthcare costs is contributing to the adoption of personalized approaches in treatment.

Technological advancements are playing a crucial role in shaping the future of the personalized medicine market. Innovations in genomic sequencing, bioinformatics, and data analytics are enhancing the ability to identify specific biomarkers and develop targeted therapies. Furthermore, the integration of artificial intelligence and machine learning is enabling healthcare providers to analyze vast amounts of data and make informed decisions regarding treatment options. As the industry continues to evolve, the personalized medicine market is likely to see increased adoption of technology-driven solutions across various healthcare settings.

Moreover, the growing emphasis on patient engagement and education is influencing the personalized medicine market's growth trajectory. As patients become more informed about their health and treatment options, there is a rising demand for personalized solutions that cater to their specific needs. This trend is driving collaboration between healthcare providers, pharmaceutical companies, and technology firms to develop educational resources and support systems that empower patients to take an active role in their healthcare decisions. As the market continues to evolve, the integration of technology, patient engagement, and personalized care will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

  • Diagnostics
  • Therapeutics
  • Personalized Medical Care
  • Others

By Application

  • Oncology
  • Cardiology
  • Neurology
  • Infectious Diseases
  • Others

By Technology

  • Genomics
  • Pharmacogenomics
  • Companion Diagnostics
  • Others

By End-User

  • Hospitals
  • Diagnostic Centers
  • Research Laboratories
  • Others
  • COMPANIES PROFILED
  • Roche
  • Thermo Fisher Scientific
  • Illumina
  • GE Healthcare
  • Abbott Laboratories
  • Danaher Corporation
  • Qiagen
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Hologic
  • Exact Sciences
  • PerkinElmer
  • Myriad Genetics
  • Foundation Medicine
  • Invitae Corporation
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PERSONALIZED MEDICINE INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Technology
    • 3.7.4 Market Attractiveness Analysis By End-User
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PERSONALIZED MEDICINE MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. Diagnostics Historic and Forecast Sales By Regions
  • 5.4. Therapeutics Historic and Forecast Sales By Regions
  • 5.5. Personalized Medical Care Historic and Forecast Sales By Regions
  • 5.6. Others Historic and Forecast Sales By Regions

6. GLOBAL PERSONALIZED MEDICINE MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Oncology Historic and Forecast Sales By Regions
  • 6.4. Cardiology Historic and Forecast Sales By Regions
  • 6.5. Neurology Historic and Forecast Sales By Regions
  • 6.6. Infectious Diseases Historic and Forecast Sales By Regions
  • 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL PERSONALIZED MEDICINE MARKET ANALYSIS BY TECHNOLOGY

  • 7.1. Overview By Technology
  • 7.2. Historical and Forecast Data Analysis By Technology
  • 7.3. Genomics Historic and Forecast Sales By Regions
  • 7.4. Pharmacogenomics Historic and Forecast Sales By Regions
  • 7.5. Companion Diagnostics Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL PERSONALIZED MEDICINE MARKET ANALYSIS BY END-USER

  • 8.1. Overview By End-User
  • 8.2. Historical and Forecast Data Analysis By End-User
  • 8.3. Hospitals Historic and Forecast Sales By Regions
  • 8.4. Diagnostic Centers Historic and Forecast Sales By Regions
  • 8.5. Research Laboratories Historic and Forecast Sales By Regions
  • 8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL PERSONALIZED MEDICINE MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PERSONALIZED MEDICINE COMPANIES

  • 10.1. Personalized Medicine Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF PERSONALIZED MEDICINE INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Roche
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Thermo Fisher Scientific
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Illumina
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. GE Healthcare
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Abbott Laboratories
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Danaher Corporation
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Qiagen
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Agilent Technologies
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Bio-Rad Laboratories
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Hologic
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Exact Sciences
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. PerkinElmer
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. Myriad Genetics
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. Foundation Medicine
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. Invitae Corporation
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies